CANCER CACHEXIA SYNDROME

Clinical trials for CANCER CACHEXIA SYNDROME explained in plain language.

Never miss a new study

Get alerted when new CANCER CACHEXIA SYNDROME trials appear

Sign up with your email to follow new studies for CANCER CACHEXIA SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

First test of new drug aimed at halting Cancer's devastating weight loss

Disease control Recruiting now

This is the first-ever study in people of an experimental drug called GB18. It aims to see if the drug is safe and how it behaves in the body. The ultimate goal is to see if GB18 could one day help control the severe, debilitating weight loss (cachexia) that affects many cancer p…

Matched conditions: CANCER CACHEXIA SYNDROME

Phase: PHASE1 • Sponsor: Shenzhen Kexing Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Mar 23, 2026 15:14 UTC

CANCER CACHEXIA SYNDROME

Get alerted when new CANCER CACHEXIA SYNDROME trials appear

First test of new drug aimed at halting Cancer's devastating weight loss